SLU-PP-332 + BAM15 300mcg

Description

The SLU-PP-332 + BAM15 300mcg combination is metabolic pharmacology’s most powerful one-two punch — two mechanistically distinct but complementary fat-burning and endurance-enhancing compounds in a single precision dose. SLU-PP-332 activates ERRα/γ to drive mitochondrial biogenesis and the oxidative muscle fibre gene expression programme. BAM15 simultaneously uncouples the mitochondria those new mitochondria contain, forcing the expanded oxidative capacity SLU-PP-332 creates to burn fuel for heat generation rather than ATP. The result is a synergistic elevation in metabolic rate: more mitochondria, each running uncoupled and burning more substrate. In animal models, the combination produced fat loss exceeding what either compound achieved individually. At 300mcg combined dose, this is a conservatively titrated entry point into the stack — allowing assessment of combined tolerability before dose escalation. This is the cutting edge of research pharmacology. Independently verified at 99%+ purity by Puralytix. Start with this conservative combined dose to establish individual synergy tolerance. Daily morning administration, taken with a modest meal containing fat, provides consistent receptor engagement. Monitoring core temperature during initial weeks provides early insight into the thermogenic contribution of BAM15 within the stack.